Articles related to Gastroenterology

Stevia’s interaction with the liver and potential effects on gut microbiome composition highlight the complexity of its impact on human health, reinforcing the importance of a nuanced approach when recommending dietary choices.

Better Therapeutics’ digital therapeutic app has been recognized with FDA breakthrough device status, showcasing its potential in significantly reducing liver fat in patients with advanced liver disease through cognitive behavioral therapy.

Mayo Clinic Children’s Center is redefining eosinophilic esophagitis (EoE) treatment with innovative diagnostic methods and a multidisciplinary approach, offering a glimpse into the future of personalized care in gastroenterology.

For patients with cirrhosis facing venous thromboembolic events, the choice of anticoagulant—be it DOACs or LMWH—demands careful consideration of their unique hemostatic profile, emphasizing the need for personalized treatment strategies.

Behçet’s syndrome presents a unique challenge in diagnosis and management, requiring a keen understanding of its diverse manifestations and the latest advances in treatment. Studies reveal a significant genetic component, with HLA-B*51 associations, underscoring the need for personalized treatment approaches.

In this Phase 3 trial, resmetirom demonstrated a notable capacity to induce NASH resolution and improve liver fibrosis, offering hope for a therapeutic breakthrough in a field with limited treatment options. This study emphasizes the importance of advancing research in liver-directed therapies for NASH.